Omeros OMER
NASDAQ OMER
$19.12 +0.01 (+0.05%)
As of: Sep 4, 2026 · 3:14 PM EDT

Omeros (OMER) Total Liabilities (2010 - 2026)

Omeros (OMER) posted Total Liabilities of $286.2 million for Q1 2026, down 12.12% sequentially from $325.6 million in Q4 2025, and up 21.69% YoY from $235.2 million in Q1 2025.

Analysis

Omeros (OMER) Total Liabilities (2010 - 2026) Analysis & Trends

Omeros has reported Total Liabilities for 17 years, with the latest figure at $286.2 million in Q1 2026.

  • Quarterly Total Liabilities rose 21.69% year-over-year to $286.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $286.2 million (up 21.69% YoY) and the FY2025 annual result came in at $325.6 million, up 17.52% from the prior year.
  • Total Liabilities eased to $286.2 million in Q1 2026 per OMER's latest filing, from $325.6 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $591.0 million in Q4 2022 and troughed at $185.7 million in Q3 2025.
  • A 5-year average of $372.9 million and a median of $356.3 million in 2024 frame the typical range for Total Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Liabilities soared 270.7% in 2022, then sank 46.25% in 2025.
  • Over 5 years, Total Liabilities stood at $591.0 million in 2022, then slumped by 35.99% to $378.3 million in 2023, then fell by 26.75% to $277.1 million in 2024, then grew by 17.52% to $325.6 million in 2025, then slipped by 12.12% to $286.2 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $286.2 million, $325.6 million, and $185.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 1.62 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 1.72 Bn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 10.03 Bn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.35 Bn
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn 338.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 338.18 Mn
Mar 31, 2026 349.51 Mn
Dec 31, 2025 446.86 Mn
Sep 30, 2025 406.18 Mn
Jun 30, 2025 429.25 Mn
Mar 31, 2025 448.71 Mn
Dec 31, 2024 459.69 Mn
Sep 30, 2024 467.51 Mn
Jun 30, 2024 480.91 Mn
Mar 31, 2024 508.82 Mn
Dec 31, 2023 403.25 Mn
Sep 30, 2023 507.02 Mn
Jun 30, 2023 506.91 Mn
Mar 31, 2023 505.20 Mn
Dec 31, 2022 505.29 Mn
Sep 30, 2022 503.87 Mn
Jun 30, 2022 378.34 Mn
Mar 31, 2022 374.19 Mn
Dec 31, 2021 395.49 Mn
Sep 30, 2021 386.13 Mn